Bridging the Gap: Addressing Affordability and Accessibility Barriers in the Global Retinal Drugs Market
Despite significant advancements in retinal drug therapies, access remains a critical challenge for many patients worldwide. High costs, limited availability in underserved regions, and barriers to reimbursement are preventing millions from accessing life-saving treatments, particularly for conditions like wet AMD and diabetic retinopathy. As the retinal drugs market grows, addressing these...
0 Σχόλια 0 Μοιράστηκε 34 Views 0 Προεπισκόπηση